Potential of Icariin Metabolites from Epimedium koreanum Nakai as Antidiabetic Therapeutic Agents

Springer Science and Business Media LLC - Tập 22 Số 6 - Trang 986
Da Hye Kim1, Hyun Ah Jung2, Hee‐Sook Sohn2, Jinwoong Kim3, Jae Sue Choi1
1Department of Food and Life Science, Pukyong National University, Busan 48513, Korea
2Department of Food Science and Human Nutrition, Chonbuk National University, Jeonju 54896 Korea
3College of Pharmacy, Seoul National University, Seoul 08826, Korea

Tóm tắt

The therapeutic properties of Epimedium koreanum are presumed to be due to the flavonoid component icariin, which has been reported to have broad pharmacological potential and has demonstrated anti-diabetic, anti-Alzheimer’s disease, anti-tumor, and hepatoprotective activities. Considering these therapeutic properties of icariin, its deglycosylated icaritin and glycosylated flavonoids (icaeriside II, epimedin A, epimedin B, and epimedin C) were evaluated for their ability to inhibit protein tyrosine phosphatase 1B (PTP1B) and α-glucosidase. The results show that icaritin and icariside II exhibit potent inhibitory activities, with 50% inhibition concentration (IC50) values of 11.59 ± 1.39 μM and 9.94 ± 0.15 μM against PTP1B and 74.42 ± 0.01 and 106.59 ± 0.44 μM against α-glucosidase, respectively. With the exceptions of icaritin and icariside II, glycosylated flavonoids did not exhibit any inhibitory effects in the two assays. Enzyme kinetics analyses revealed that icaritin and icariside II demonstrated noncompetitive-type inhibition against PTP1B, with inhibition constant (Ki) values of 11.41 and 11.66 μM, respectively. Moreover, molecular docking analysis confirmed that icaritin and icariside II both occupy the same site as allosteric ligand. Thus, the molecular docking simulation results were in close agreement with the experimental data with respect to inhibition activity. In conclusion, deglycosylated metabolites of icariin from E. koreanum might offer therapeutic potential for the treatment of type 2 diabetes mellitus.

Từ khóa


Tài liệu tham khảo

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183–1197.

Parthasarathy, 2009, Antidiabetic activity of Thespesia Populnea bark and leaf extract against streptozotocin induced diabetic rats, Int. J. PharmTech. Res., 1, 1069

Kwon, 2008, Triterpenoids and a sterol from the stem-bark of Styrax japonica and their protein tyrosine phosphatase 1B inhibitory activities, Phytother. Res., 22, 1303, 10.1002/ptr.2484

Elchebly, 1999, Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene, Science, 283, 1544, 10.1126/science.283.5407.1544

Liu, 2015, Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice, Toxicol. Appl. Pharmacol., 285, 61, 10.1016/j.taap.2015.03.011

Shobana, 2009, Composition and enzyme inhibitory properties of finger millet (Eleusine coracana L.) seed coat phenolics: Mode of inhibition of α-glucosidase and pancreatic amylase, Food Chem., 115, 1268, 10.1016/j.foodchem.2009.01.042

Choi, 2010, Yeast α-glucosidase inhibition by isoflavones from plants of Leguminosae as an in vitro alternative to acarbose, J. Agric. Food Chem., 58, 9988, 10.1021/jf101926j

Chiba, 1997, Molecular mechanism in α-glucosidase and glucoamylase, Biosci. Biotechnol. Biochem., 61, 1233, 10.1271/bbb.61.1233

Lucassen, 2005, α-Glucosidase inhibitors for patients with type 2 diabetes results from a cochrane systematic review and meta-analysis, Diabetes Care, 28, 154, 10.2337/diacare.28.1.154

Etxeberria, 2012, Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase, Expert Opin. Ther. Targets, 16, 269, 10.1517/14728222.2012.664134

Nakashima, 2016, Two new prenylflavonoids from Epimedii Herba and their inhibitory effects on advanced glycation end-products, J. Nat. Med., 70, 290, 10.1007/s11418-015-0962-0

Chen, 2015, Chemical constituents, quality control, and bioactivity of Epimedii Folium (Yinyanghuo), Am. J. Chin. Med., 43, 783, 10.1142/S0192415X15500494

Wu, 2003, Chemical and pharmacological investigations of Epimedium species: A survey, Prog. Drug Res., 60, 1

Oh, 2004, Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity, Phytomedicine, 11, 544, 10.1016/j.phymed.2004.03.001

Oh, 2013, Anti-diabetic effect of medicinal plants used for lower wasting-thirst in streptozotocin-induced diabetic rats, Korea J. Herbol., 28, 53, 10.6116/kjh.2013.28.5.53

Makarova, 2007, Effect of lipid-based suspension of Epimedium koreanum Nakai extract on sexual behavior in rats, J. Ethnopharmacol., 114, 412, 10.1016/j.jep.2007.08.021

Kang, 2012, Estrogenic/antiestrogenic activities of a Epimedium koreanum extract and its major components: In vitro and in vivo studies, Food Chem. Toxicol., 50, 2751, 10.1016/j.fct.2012.05.017

Cho, 2012, Epimedium koreanum Nakai water extract exhibits antiviral activity against porcine epidermic diarrhea virus in vitro and in vivo, Evid. Based Complement. Alternat. Med., 2012, 985151, 10.1155/2012/985151

Keum, 2014, Analysis and stability test of the extracts from Epimedii Herba, Atractylodis Rhizoma Alba and Polygalae Radix for toxicity study, Korea J. Pharmacogn., 45, 135

Li, 1998, Complete assignment of 1H- and 13C-NMR spectra of ikarisoside A and epimedoside C, Magn. Reson. Chem., 36, 303, 10.1002/(SICI)1097-458X(199804)36:4<303::AID-OMR187>3.0.CO;2-I

Li, 1995, A 9,10-dihydrophenanthrene derivate from Epimedium koreanum, Phytochemistry, 39, 231, 10.1016/0031-9422(94)00926-K

Lee, 1995, Antihepatotoxic activity of icariin, a major constituent of Epimedium koreanum, Planta Med., 61, 523, 10.1055/s-2006-959362

Zhou, 2011, Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions, Int. Immunopharmacol., 11, 890, 10.1016/j.intimp.2011.01.007

Xu, 2007, Vasorelaxant effects of icariin on isolated canine coronary artery, J. Cardiovasc. Pharmacol., 49, 207, 10.1097/FJC.0b013e3180325abe

Tohda, 2012, Epimedium koreanum extract and its constituent icariin improve motor dysfunction in spinal cord injury, Evid. Based Complement. Alternat. Med., 2012, 731208, 10.1155/2012/731208

Zhang, 2014, Icariin decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of Alzheimer’s disease, Int. J. Biol. Sci., 10, 181, 10.7150/ijbs.6232

Xin, 2012, Icariin ameliorates streptozotocin-induced diabetic retinopathy in vitro and in vivo, Int. J. Mol. Sci., 13, 866, 10.3390/ijms13010866

Chen, 2016, Neuroprotective effects of icariin on brain metabolism, mitochondrial functions, and cognition in triple-transgenic Alzheimer’s disease mice, CNS Neurosci. Ther., 22, 63, 10.1111/cns.12473

Lin, 1999, Effects of icariside II from Epimedium koreanum on tumour cell lines in vitro, Pharm. Pharmacol. Commun., 5, 701, 10.1211/146080899128734424

Cho, 1995, Anti-hepatotoxic activity of icariside II, a constituent of Epimedium koreanum, Arch. Pharm. Res., 18, 289, 10.1007/BF02976415

Yin, 2016, Icariside II, a novel phosphodiesterase-5 inhibitor, attenuates streptozotocin-induced cognitive deficits in rats, Neuroscience, 328, 69, 10.1016/j.neuroscience.2016.04.022

Huang, 2007, A novel anticancer agent, icaritin, induced cell growth inhibition, G 1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells, Eur. J. Pharmacol., 564, 26, 10.1016/j.ejphar.2007.02.039

Guo, 2011, An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells, Eur. J. Pharmacol., 658, 114, 10.1016/j.ejphar.2011.02.005

Wang, 2007, Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway, Neuroscience, 145, 911, 10.1016/j.neuroscience.2006.12.059

Zhang, 2013, Epimediphine, a novel alkaloid from Epimedium koreanum inhibits acetylcholinesterase, Nat. Prod. Res., 27, 1067, 10.1080/14786419.2012.708660

Morris, 2009, AutoDock 4 and AutoDockTools 4: Automated docking with selective receptor flexibility, J. Comput. Chem., 30, 2785, 10.1002/jcc.21256

International Diabetes Federation (IDF) (2015). IDF Diabetes Atlas, International Diabetes Federation. [7th ed.].

Wang, 2015, Natural and semisynthetic protein tyrosine phosphatase 1B (PTP1B) inhibitors as anti-diabetic agents, RSC Adv., 5, 48822, 10.1039/C5RA01754H

Bongard, 2017, Serendipitous discovery of lightinduced (In Situ) formation of an Azo-bridged dimeric sulfonated naphthol as a potent PTP1B inhibitor, BMC Biochem., 18, 1, 10.1186/s12858-017-0083-3

Gubiani, 2017, An epigenetic modifier induces production of (10'S)-verruculide B, an inhibitor of protein tyrosine phosphatases by Phoma sp. nov. LG0217, a fungal endophyte of Parkinsonia microphylla, Bioorg. Med. Chem., 25, 1860, 10.1016/j.bmc.2017.01.048

Jung, H.A., Ali, M.Y., and Choi, J.S. (2016). Promising inhibitory effects of anthraquinones, naphthopyrone, and naphthalene glycosides, from Cassia obtusifolia on α-glucosidase and human protein tyrosine phosphatases 1B. Molecules, 22.

Meng, 2005, Osteoblastic proliferation stimulating activity of Epimedium koreanum. Nakai extracts and its flavonol glycosides, Pharm. Biol., 43, 92, 10.1080/13880200590903435

Huang, 2013, An integrated plasma and urinary metabonomic study using UHPLC–MS: Intervention effects of Epimedium koreanum on ‘Kidney-Yang Deficiency syndrome’ rats, J. Pharm. Biomed. Anal., 76, 200, 10.1016/j.jpba.2012.12.022

Islam, 2012, High-performance liquid chromatography-based multivariate analysis to predict the estrogenic activity of an Epimedium koreanum extract, Biosci. Biotechnol. Biochem., 76, 923, 10.1271/bbb.110922

Phan, 2013, Evaluation of α-glucosidase inhibition potential of some flavonoids from Epimedium brevicornum, LWT-Food Sci. Technol., 53, 492, 10.1016/j.lwt.2013.04.002

Kumar, 2014, Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins, Mol. BioSyst., 10, 891, 10.1039/C3MB70537D

Seong, 2016, Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents, J. Ethnopharmacol., 194, 706, 10.1016/j.jep.2016.10.007

Baskaran, 2012, Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid, J. Chem. Inf. Model., 52, 2004, 10.1021/ci200581g

Huang, 2014, ASD v2. 0: Updated content and novel features focusing on allosteric regulation, Nucleic Acids Res., 42, D510, 10.1093/nar/gkt1247

Li, S., Zhang, J., Lu, S., Huang, W., Geng, L., Shen, Q., and Zhang, J. (2014). The mechanism of allosteric inhibition of protein tyrosine phosphatase 1B. PLoS ONE, 9.

Lee, 2007, Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B, Med. Res. Rev., 27, 553, 10.1002/med.20079

Choi, 2015, Protein tyrosine phosphatase 1B inhibitory activity of alkaloids from Rhizoma Coptidis and their molecular docking studies, J. Ethnopharmacol., 171, 28, 10.1016/j.jep.2015.05.020

Wu, H., Kim, M., and Han, J. (2016). Icariin metabolism by human intestinal microflora. Molecules, 21.

Bao, 2011, Icariin reduces mitochondrial oxidative stress injury in diabetic rat hearts, Zhongguo Zhong Yao Za Zhi, 36, 1503

Ma, 2015, Protective effects of icariin on cisplatin-induced acute renal injury in mice, Am. J. Transl. Res., 7, 2105

Tian, 2015, Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats, Drug Des. Devel. Ther., 9, 5147

Zhang, 2015, Icaritin attenuates myocardial ischemia and reperfusion injury via anti-inflammatory and anti-oxidative stress effects in rats, Am. J. Chin. Med., 43, 1083, 10.1142/S0192415X15500627

Jin, 2012, Statistically designed enzymatic hydrolysis of an icariin/β-cyclodextrin inclusion complex optimized for production of icaritin, Acta Pharm. Sin. B, 2, 83, 10.1016/j.apsb.2011.12.004

Liu, 2005, Preparative isolation and purification of three flavonoids from the Chinese medicinal plant Epimedium koreamum Nakai by high-speed counter-current chromatography, J. Chromatogr. A, 1064, 53, 10.1016/j.chroma.2004.12.026

Xiong, W., Ma, X., Wu, Y., Chen, Y., Zeng, L., Liu, J., Sun, W., Wang, D., and Hu, Y. (2015). Determine the structure of phosphorylated modification of icariin and its antiviral activity against duck hepatitis virus A. BMC Vet. Res., 11.

Ito, 1988, Three flavonol glycosides from Epimedium koreanum, Phytochemistry, 27, 911, 10.1016/0031-9422(88)84118-9

Cui, 2006, Protein tyrosine phosphatase 1B inhibitors from Morus root bark, Bioorg. Med. Chem. Lett., 16, 1426, 10.1016/j.bmcl.2005.11.071

Li, 2005, A microplate-based screening method for alpha-glucosidase inhibitors, Chin. J. Clin. Pharmacol. Ther., 10, 1128

Lineweaver, 1934, The determination of enzyme dissociation constants, J. Am. Chem. Soc., 56, 658, 10.1021/ja01318a036

Dixon, 1953, The determination of enzyme inhibitor constants, Biochem. J., 55, 170, 10.1042/bj0550170

1974, A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors, Biochem. J., 137, 143, 10.1042/bj1370143

Bernstein, 1977, The protein data bank: A computer-based archival file for macromolecular structures, Eur. J. Biochem., 80, 319, 10.1111/j.1432-1033.1977.tb11885.x

Berman, 2002, The protein data bank, Acta Crystallogr. D Biol. Crystallogr., 58, 899, 10.1107/S0907444902003451

Wiesmann, 2004, Allosteric inhibition of protein tyrosine phosphatase 1B, Nat. Struct. Mol. Biol., 11, 730, 10.1038/nsmb803

Pettersen, 2004, UCSF Chimera—A visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084